Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran

Clinical trial NCT04928313 · COMPLETED

Trial details

NCT number: NCT04928313
Sponsor: Cinnagen
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2015-04-12
Primary completion: 2020-02-17
Enrollment: 368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.